Pharmaceutical Research and Manufacturers of America
Registered Principal Details
Business Or Interest:
Research and manufacturing pharmaceuticals organizations.
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.
CEO Name:
John Castellani
Regional Director
Research and manufacturing pharmaceuticals organizations.
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.
CEO Name:
John Castellani
Regional Director
Contact
LC
Linda Carroll-Shern
55 E Fifth St Ste 1255
St. Paul, MN 55101
(651) 224-4548
(651) 224-4084
LShern@phrma.org
55 E Fifth St Ste 1255
St. Paul, MN 55101
(651) 224-4548
(651) 224-4084
LShern@phrma.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Thomas E Moore | Exclusive Duties N/A | Authorized On 1/6/2011 | Withdrawn On N/A |
| Steven Foti | Exclusive Duties N/A | Authorized On 1/6/2011 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
September 2011 Special Session Assembly Bill 13
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
Bill Text and History
10/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
Bill Text and History
For
Notification Date10/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
September 2011 Special Session Senate Bill 13
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
Bill Text and History
10/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
Bill Text and History
For
Notification Date10/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Medical Assistance and Related Programs
Health Services: Medical Assistance and Related Programs
Notification Date
4/12/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Medical Assistance funding related to MA prescription drug benefits
4/12/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Medical Assistance funding related to MA prescription drug benefits
Biennial budget bill treatment of matter relating to
Regulation and Licensing
Regulation and Licensing
Notification Date
4/12/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Related to the proposed expansion of the Pharmacy Scope of Practice
4/12/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
Related to the proposed expansion of the Pharmacy Scope of Practice
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Dual eligible demonstration projects
Dual eligible demonstration projects
Action Intended To Affect
Legislative matter
Notification Date
11/21/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
11/21/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
State health care exchanges
State health care exchanges
Action Intended To Affect
Legislative matter
Notification Date
11/21/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
11/21/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
LRB-2890/2 related to immunity from liability to drug and device manufacturers and sellers under certain circumstances
Development, drafting or introduction of a proposal relating to
LRB-2890/2 related to immunity from liability to drug and device manufacturers and sellers under certain circumstances
LRB-2890/2 related to immunity from liability to drug and device manufacturers and sellers under certain circumstances
Action Intended To Affect
Legislative Matter
Notification Date
10/6/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
10/6/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
DHFS plan to move the Medicaid managed care pharmacy benefit to Medicaid fee-for-service
DHFS plan to move the Medicaid managed care pharmacy benefit to Medicaid fee-for-service
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Issues related to the discovery, development, detailing, sales and maketing of prescription drugs.
Issues related to the discovery, development, detailing, sales and maketing of prescription drugs.
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Resolution to Congress RE: SCHIP reauthorization
Resolution to Congress RE: SCHIP reauthorization
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Wholesale licensure of prescription drugs
Wholesale licensure of prescription drugs
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2011 January - June $57,840.52 |
2011 July - December $25,645.62 |
2012 January - June $46,998.91 |
2012 July - December $50,594.54 |
Total $181,079.59 |
| Total Hours Communicating | 2011 January - June 35.50 |
2011 July - December 20.50 |
2012 January - June 23.50 |
2012 July - December 7.50 |
Total 87.00 |
| Total Hours Other | 2011 January - June 66.50 |
2011 July - December 33.50 |
2012 January - June 70.00 |
2012 July - December 40.75 |
Total 210.75 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December 10% |
2012 January - June |
2012 July - December |
Total 2% |
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December 45% |
2012 January - June |
2012 July - December |
Total 8% |
Budget Bill Subjects
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 15% |
2011 July - December |
2012 January - June |
2012 July - December |
Total 5% |
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 60% |
2011 July - December 25% |
2012 January - June 25% |
2012 July - December 13% |
Total 35% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June 15% |
2011 July - December |
2012 January - June 12% |
2012 July - December |
Total 9% |
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December |
2012 January - June 8% |
2012 July - December |
Total 3% |
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December |
2012 January - June 10% |
2012 July - December |
Total 3% |
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December 10% |
Total 2% |
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December 20% |
Total 3% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication